Work

Systemic and ocular safety of bevacizumab gamma: Pooled analysis of 432 eyes with neovascular age-related macular degeneration (nAMD) across the NORSE clinical programme

Year: 2026

Type: conference-paper

Abstract: Purpose: To analyse pooled safety data of intravitreal bevacizumab gamma across all trials included within the NORSE clinical programme for nAMD. Methods: Post-hoc safety analysis included all eyes receiving ≥1 intravitreal injection of bevacizumab gamma for nAMD across the NORSE clinical [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/26doc034

Authors: Khoramnia, Ramin, Siedlecki, Jakob, Thelen, Ulrich

Institutions: University Hospital Carl Gustav Carus, LMU Klinikum, Ludwig-Maximilians-Universität München

Language: English

Topic: Retinal Diseases and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7165014965